WHO GRADE II GLIOMA
Clinical trials for WHO GRADE II GLIOMA explained in plain language.
Never miss a new study
Get alerted when new WHO GRADE II GLIOMA trials appear
Sign up with your email to follow new studies for WHO GRADE II GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for young brain tumor patients: drug duo targets genetic mutations
Disease control OngoingThis early-stage study tests a new drug (BGB-290) combined with chemotherapy (temozolomide) in adolescents and young adults with IDH1/2-mutant gliomas, a type of brain tumor. The goal is to find the safest dose and check for side effects. About 78 participants with newly diagnose…
Matched conditions: WHO GRADE II GLIOMA
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 26, 2026 11:28 UTC
-
New radiation approach aims to treat brain tumors while saving the scalp
Disease control OngoingThis study tests a precise type of radiation therapy for people with newly diagnosed brain tumors (grade II-IV glioma). The goal is to see if this technique can effectively treat the tumor while reducing damage to the scalp and lowering the risk of infection or other wound proble…
Matched conditions: WHO GRADE II GLIOMA
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New pill targets brain tumor gene in early trial
Disease control OngoingThis study tests an experimental drug called DS-1001b in 25 people with a type of slow-growing brain tumor (grade II glioma) that has a specific IDH1 gene mutation. Participants have not had chemotherapy or radiation before. The goal is to see if the drug can shrink or control th…
Matched conditions: WHO GRADE II GLIOMA
Phase: PHASE2 • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC